Shingles vaccine candidate strongly immunogenic in a Phase 3 trial

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2017年 / 13卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1734 / 1734
页数：1
相关论文
共 50 条
  • [31] Identification of the most immunogenic regions in vaccine candidate P6
    Bettinger, John
    Newman, Emily
    Mangan, Anthony
    Pichichero, Michael
    Michel, Lea
    FASEB JOURNAL, 2014, 28 (01):
  • [32] Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants
    Chargelegue, D
    Drake, PAW
    Obregon, P
    Prada, A
    Fairweather, N
    Ma, JKC
    INFECTION AND IMMUNITY, 2005, 73 (09) : 5915 - 5922
  • [33] Staphylococcus aureus vaccine candidate enters phase 2b trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (09) : 2122 - 2122
  • [34] Smallpox vaccine passed Phase 3 trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (04) : 802 - 802
  • [35] Zika vaccine proved safe and immunogenic in early trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (12) : 2753 - 2753
  • [36] Colorectal cancer vaccine is safe and immunogenic in an early trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (06) : 1203 - 1203
  • [37] Optimising the M72/AS01E tuberculosis vaccine candidate phase 3 trial based on the phase 2b trial results
    Dale, Katie D.
    Denholm, Justin T.
    VACCINE, 2025, 49
  • [38] New glioblastoma vaccine: Safe and immunogenic in phase 1
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (06) : 1427 - 1427
  • [39] GSK scores first Phase III shingles trial success
    Asher Mullard
    Nature Reviews Drug Discovery, 2015, 14 : 373 - 373
  • [40] Immunogenic characteristics of the outer membrane phosphoporin as a vaccine candidate against Klebsiella pneumoniae
    Gaowei Hu
    Xue Chen
    Wenhui Chu
    Zhe Ma
    Yingjie Miao
    Xi Luo
    Yongqian Fu
    Veterinary Research, 53
12345